iXensor’s Eveline·Care telehealth empowering fertility services to assist patients’ conceptions with at-home test monitoring

Palo Alto, California / Taipei, Taiwan, September 14th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, launches its new Eveline·Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly…

read more

iXensor levels up PixoTest® COVID-19 Ag Test with the launch of PixoHealth data management platform as the security solution for the new normalcy

PixoHealth Pass Admin App and Web Portal empowers safer reopening in the post-pandemic era

The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta Connected point-of-care screening is the critical security mechanism of the post-pandemic normalcy  …

read more

iXensor digitizes COVID-19 antigen test with easy-to-use mobile app

Business Next’s interview with iXensor CEO Dr. Carson Chen reveals how iXensor developed its fully digitalized end-to-end COVID-19 screening solution based on its proprietary PixoTech platform. In addition to infectious disease, iXensor has turned smartphones into lab-grade diagnostic devices through PixoTech to address chronic disease and women’s health challenges. Read…

read more

PixoTest® POCT COVID-19 Antigen Test Covered in MobiHealthNews

PixoTech-Covid-19-PixoHeal-Pass

iXensor has recently announced that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. MobiHealthNews and other media covered the end-to-end fully digitalised rapid screening solution features: “It comprises a palm-sized analyser, a digital health pass app, an admin app and a HIPAA-grade health management web portal. Its diagnostic solution…

read more

iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies

iXensor launches CE marked PixoTest COVID-19 Antigen Test

iXensor, the pioneer of mobile health, announces today that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. iXensor provides the end-to-end fully digitalized solution to prevent further outbreaks. iXensor’s PixoTest® solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin…

read more

PixoTest POCT COVID-19 Antigen Test Covered in Med-Tech Innovation News

How-smartphone-technology-can-aid-COVID-19-testing-Med-Tech-Innovation-Latest-news-for-the-medical-device-industry

Med-Tech Innovation News talks about how iXensor can bring smartphone technology to aid COVID-19 testing. Bringing the end-to-end digital COVID-19 screening solution PixoTest® POCT COVID-19 Antigen Testing, iXensor is ready to help organizations preventing outbreaks. “PixoTest provides computer analyzed COVID-19 test results, lowering the risks caused by misinterpretation of human eyes. The…

read more